久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • Spero Therapeutics Announces Proposed Offering of Common Stock firstwordpharma
    July 10, 2018
    Spero Therapeutics, Inc. (Nasdaq:SPRO) (Spero), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multidrug-resistant (MDR) bacterial infections
  • Spero Therapeutics Receives Grant from NIH americanpharmaceuticalreview
    May 05, 2017
    Spero Therapeutics announced it has received a grant from the National Institutes of Health (NIH) to conduct additional preclinical studies of SPR720, the company's novel oral bacterial gyrase inhibitor, for the treatment of tuberculosis (TB).
PharmaSources Customer Service